rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OPK
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Why Pony AI Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
      19h agoBenzingaOPK
      Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury
      Nov 17Yahoo FinanceOPK
      Kopin: Q3 Earnings Snapshot
      Nov 10Yahoo FinanceKOPNOPK
      Orthofix (OFIX) Surpasses Q3 Earnings Estimates
      Nov 9Yahoo FinanceOPK
      Orthofix: Q3 Earnings Snapshot
      Nov 9Yahoo FinanceOPK
      Is OPKO Health (OPK) A Bargain As New Results And Guidance Reset Valuation?
      Nov 8Yahoo FinanceOPK
      How Investors May Respond To OPKO Health (OPK) Updated Revenue Guidance
      Nov 8Yahoo FinanceOPK
      Opko Health director John Paganelli sells $24,576 in shares
      Nov 5Investing.comOPK
      OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ...

      OPKO Health Inc (OPK) posted $65.4 million in Q3 2026 revenue and a $722 million LabCorp cash windfall, while widening biotech losses and a delayed CAR-T timeline tempered the outlook.

      Nov 5Yahoo FinanceOPK
      OPKO Health (OPK) Reports Q3 Loss, Misses Revenue Estimates
      Nov 4Yahoo FinanceOPK
      OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results

      MIAMI, Nov. 04, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical company, today reports business high...

      Nov 4Business InsiderOPK
      OPKO Health Q3 2026 Earnings Call Transcript
      Nov 4BenzingaOPK
      OPKO Health: Q3 Earnings Snapshot
      Nov 4Yahoo FinanceOPK
      Opko Health earnings matched, revenue fell short of estimates
      Nov 4Investing.comOPK
      Opko Health earnings on deck as diagnostics exit reshapes company
      Nov 4Investing.comOPK
      OPKO Health (OPK) Q3 2026 Earnings Call Transcript

      Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

      Nov 4The Globe and MailOPK
      Opko Health stock hits 52-week high at 1.77 USD
      Nov 3Investing.comOPK
      OPKO Health (OPK) Stock Looks Pricey As Focus Turns To Its 58% Five Year Fall
      Nov 3Yahoo FinanceOPK
      OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
      Oct 28Yahoo FinanceOPK
      OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly

      KIRYAT GAT, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Biologics Ltd., an OPKO Health company (NASDAQ: OPK), today announced that the first ...

      Oct 27Business InsiderOPK
      OPKO Biologics doses first patient in acromegaly drug trial
      Oct 27Investing.comOPK
      OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides
      Oct 17Yahoo FinanceOPK
      Is OPKO Health (OPK) Pricing In Too Much For Sales?
      Oct 17Yahoo FinanceOPK
      Piper Sandler raises Opko Health stock price target on LabCorp deal
      Oct 16Investing.comOPKLH
      OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
      Oct 16Yahoo FinanceOPK
      Opko Health stock hits 52-week high at 1.75 USD
      Oct 16Investing.comOPK
      H.C. Wainwright reiterates Opko Health stock rating on Labcorp deal
      Oct 16Investing.comOPKLH
      Barrington Upgrades OPKO Health to Outperform From Market Perform, Sets $2.25 Price Target
      Oct 16Yahoo FinanceOPK
      Why Is Opko Health Stock Gaining Thursday? - OPKO Health (NASDAQ:OPK), Labcorp Holdings (NYSE:LH)
      Oct 15BenzingaOPKLH
      Penske Automotive, OPKO Health, Ericsson And Other Big Stocks Moving Higher On Thursday
      Oct 15BenzingaERICOPKPAGSAH
      Why is Opko Health stock surging today?
      Oct 15Investing.comOPK
      Opko Health stock soars on $722M BioReference asset sale
      Oct 15Investing.comOPK
      Labcorp to buy select assets from Opko Health unit for up to $872 million
      Oct 15ReutersOPKLH
      Labcorp to Acquire Certain Assets of OPKO Health's BioReference Health Subsidiary for $722 Million
      Oct 15Yahoo FinanceOPKLH
      Labcorp to buy assets of OPKO’s BioReference Health (LH:NYSE)
      Oct 15Seeking AlphaOPKLH
      Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
      Oct 15Yahoo FinanceOPKLH
      Cautionary Tales On Why You Should Ignore Insider Buying (NYSEARCA:SURE)

      Insiders at American Airlines, Opko Health, Intel, Bed Bath & Beyond, and Align Technology expressed great confidence in their companies. Read more here.

      Oct 7Seeking AlphaALGNBBBYOPK
      Here's Why You Should Retain OPK Stock in Your Portfolio for Now

      OPKO Health eyes growth from RAYALDEE, partner revenues and a leaner BioReference, while pipeline and reimbursement risks remain key concerns.

      Sep 28Yahoo FinanceOPK
      Opko Health stock hits 52-week high at 1.74 USD
      Sep 22Investing.comOPK
      OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?
      Sep 21Yahoo FinanceOPK
      The Bull Case For OPKO Health (OPK) Could Change Following New Mazdutide Royalty-Backed Financing Strategy

      Earlier this month, OPKO Health expanded its financing relationship with HealthCare Royalty by issuing US$125 million in senior secured notes backed by future mazdutide royalty payments from China, allowing it to raise capital without issuing new shares and with total repayments capped at 1.5 times the amount received. This royalty-backed financing structure highlights how OPKO Health is using its metabolic therapy partnerships to access non-dilutive funding while preserving potential...

      Sep 16Yahoo FinanceOPK
      OPKO Health (OPK) Cashes In A Future Royalty Stream Early

      On August 13, OPKO Health (NASDAQ:OPK) expanded its financing relationship with HealthCare Royalty, a business of KKR, issuing an additional $125 million in senior secured notes secured by the royalty stream tied to mazdutide, the GLP-1 drug OPKO licensed to Eli Lilly and now collects royalties on in China. The notes mature in 2044, matching […]

      Sep 14Yahoo FinanceOPK
      OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months

      OPKO Health (NASDAQ:OPK) outlined a strategy to shift its business mix toward therapeutics while continuing to streamline its diagnostics operations, with management highlighting a pipeline of early-stage clinical programs, external collaborations and capital available to fund development. Speaking

      Sep 11Yahoo FinanceOPK
      OPKO Health at Wells Fargo conference: cash-rich pivot to therapeutics
      Sep 10Investing.comOPKWFC
      OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
      Sep 8Yahoo FinanceOPK
      Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report?

      OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Aug 26Yahoo FinanceOPK
      Here's Why You Should Retain OPK Stock in Your Portfolio for Now

      OPKO Health's growth outlook is supported by RAYALDEE, strategic partnerships, BioReference restructuring and multiple pipeline catalysts.

      Aug 24Yahoo FinanceOPK

      This is the newest page. Registered accounts read further back.